Search Results - "Miller, Merlene"

Acute Intravenous Synaptamine Complex Variant KB220™ "Normalizes" Neurological Dysregulation in Patients during Protracted Abstinence from Alcohol and Opiates as Observed Using Quantitative Electroencephalographic and Genetic Analysis for Reward Polymorphisms: Part 1, Pilot Study with 2 Case Reports by Miller, David K., Bowirrat, Abdalla, Manka, Matthew, Miller, Merlene, Stokes, Stanley, Manka, Debra, Allen, Cameron, Gant, Charles, Downs, B. William, Smolen, Andrew, Stevens, Emily, Yeldandi, Swetha, Blum, Kenneth

“…It is well established that in both food- and drug-addicted individuals, there is dopamine resistance due to an association with the DRD2 gene A1 allele…”
Get full text

Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)™ Improves Behavioral Outcomes in a Residential Addiction Treatment Program: A Pilot Study by Miller, Merlene, Chen, Amanda LC, Stokes, Stan D., Silverman, Susan, Bowirrat, Abdalla, Manka, Matthew, Manka, Debra, Miller, David K., Perrine, Kenneth, Chen, Thomas JH, Bailey, John A., Downs, William, Waite, Roger L., Madigan, Margaret A., Braverman, Eric R., Damle, Uma, Kerner, Mallory, Giordano, John, Morse, Siobhan, Oscar-Berman, Marlene, Barh, Debmalya, Blum, Kenneth

“…Substance use disorders (SUD) are inheritable and the culprit is hypodopaminergic function regulated by reward genes. We evaluated a natural dopaminergic…”
Get full text